Tag Archives: science policy

Basket Trials: Accelerating Precision Medicine

By | July 11, 2017

On May 23rd 2017, the cancer research community applauded a landmark accomplishment when for the first time the U.S. Food and Drug Administration (FDA) approved Merck’s pembrolizumabfor use in tumors located in any tissue. While cancers are traditionally organized and treated based on their tissue of origin, tumor sequencing has demonstrated that there are important… Read More »

The Week in Science and Science Policy April 23rd-30th

By | May 1, 2017

1. The problem of secrets in private biotech In the face of potential cuts to federal science funding, private industry is increasingly a potential source of research funding. While federal funding peaked in the middle of the last century, private funding has only been increasing, and will continue to. This does not mean that private… Read More »

My Picks in Science Policy April 16th-April 23rd

By | April 24, 2017

Of course, the big news this week was the Science March. With practically every news outlet hosting think-pieces and op-eds about the march, it seemed like other articles about science and science policy were pushed out of the public eye a bit. I’ll share a list of science march articles at the end, but for… Read More »

My picks in Science Policy April 9th-15th

By | April 16, 2017

1. The problems with cancer research cell lines As a cancer biologists, there are several breast cancer cell lines I use every day. Some of these are derived from human tumors, some from mouse tumors that closely mimic what we see in human patients. However, we’ve known for a long time that cell lines don’t… Read More »

My Picks in Science Policy March 17-24

By | March 26, 2017

  1. What should the role of NASA be going forwards? Federal funding plays a crucial role in high-risk, low-return discoveries. These lay the foundation for future research and industry, fostering economic growth. One of the best examples of this is with the space industry, while NASA conducted the initial research and exploration, it is now… Read More »

The best reads in science/science policy 02/24/17–03/03/17

By | March 7, 2017

1. The deep ties between Patient Groups and Industry One of the last bills passed under President Obama was the 21st Century Cures Act, which was purportedly meant to expand biomedical research and increase the speed by which new drugs reach patients (see my opinion on it here). The drafting of the act was an epic battle… Read More »

Trump’s fetishization of the Great Man Theory

By | March 7, 2017

Originally published on Medium It is an extremely attractive story, and one that we’ve seen before. A child is deathly ill, and when doctors are stymied a parent does everything they can to discover the cure. In fact, Hollywood has been quick to turn this tale into movies. In 1992, Nick Nolte and Susan Sarandon starred… Read More »

The best reads in Science Policy 02/20/17–02/27/17

By | March 7, 2017

1. AAAS stands with the March for Science My own feelings towards the March for Science have been very mixed. I think it’s important for scientists to be active in the name of science, but I worry about tying science to partisanship. Even though the organizers have stated the march is “not about scientists or politicians”, it’s… Read More »